Even after ALS had silenced her vocal chords, Barbara Brenner’s powerful voice continued to send tremors into the medical establishment.
With the assistance of a text-to-speech computer program, Brenner, the former executive director of Breast Cancer Action, sent stinging missives to the head of the ALS clinical trials program and Food and Drug Administration officials, and continued her less public work